Caretek Med Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.80 M
- Revenue Growth %
- Net Worth 230.37%
- Total Assets 6164.61%
About Caretek Med
Caretek Med Private Limited (CMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2020 (Five years 26 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.80 M.
Jaykumar Balmiki and Ashvini Balmiki serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2020PTC336050
-
Company No.
336050
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jan 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Caretek Med?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaykumar Balmiki
|
Director | 14-Jan-2020 | Current |
|
Ashvini Balmiki
|
Director | 14-Jan-2020 | Current |
Financial Performance of Caretek Med.
Caretek Med Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 230.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caretek Med?
Unlock access to Caretek Med's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ally-Bio Private LimitedJaykumar Balmiki and Ashvini Balmiki are mutual person
-
Bioarch Systems Private LimitedJaykumar Balmiki is a mutual person
Charges (Loans)
₹4.80 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2022 | State Bank Of India | ₹4.80 M | Open |
How Many Employees Work at Caretek Med?
Unlock and access historical data on people associated with Caretek Med, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caretek Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caretek Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.